WeLeader Biomedical Co., Ltd. (7713.TWO)

TWD 57.7

(0.35%)

Annual Cash Flows

(In TWD)
Breakdown 2023 2022 2021 2020
Operating Cash Flow 231.86 Million 280.26 Million 238.02 Million 172.78 Million
Net Income 193.54 Million 192.54 Million 131.45 Million 61.27 Million
Depreciation & Amortization 103.8 Million 109.82 Million 114.44 Million 109.35 Million
Deferred income taxes - - - -
Stock-based compensation 176 Thousand 4.22 Million 3.65 Million -
Change in working capital -5.94 Million 4.55 Million 1.7 Million 6.74 Million
Other non-cash items 5.1 Million 3.97 Million 6.08 Million 8.51 Million
Investing Cash Flow -113.95 Million -665.27 Million -2.7 Million -32.49 Million
Investments in PPE -115.73 Million -661.65 Million -23.89 Million -38.06 Million
Acquisitions - - - -
Investment purchases 825 Thousand -4.68 Million -18.01 Million -
Sales/Maturities of investments - - 38.78 Million 5.44 Million
Other Investing Activities -48 Thousand - - -
Financing Cash Flow -123.94 Million 374.21 Million -225.96 Million -73.65 Million
Debt repayment -83.27 Million -320.99 Million -124.19 Million -34.86 Million
Dividends payments -29.75 Million -9.77 Million -22.35 Million -32.76 Million
Common Stock Repurchased - - - -
Common Stock Issuance 61.48 Million 143.64 Million - -
Other Financing Activities -72.39 Million -20 Thousand - 204 Thousand
Accounts receivables 6.31 Million - - -
Accounts payables - - - -
Inventory -5.77 Million -7.1 Million -13.37 Million -20.35 Million
Other working capital -6.49 Million - - -
Cash at beginning of period 100.72 Million 111.51 Million 102.16 Million 35.51 Million
Cash at end of period 94.69 Million 100.72 Million 111.51 Million 102.16 Million
Capital Expenditure -115.73 Million -661.65 Million -23.89 Million -38.06 Million
Effect of forex changes on cash - - - -
Net cash flow / Change in cash -6.03 Million -10.78 Million 9.35 Million 66.64 Million
Free Cash Flow 116.13 Million -381.38 Million 214.13 Million 134.72 Million

Cash Flow Charts